LCS
Device Ortho-Knee
PDI 10603295021438
General payments
$3,805,367
Research payments
$894,700
Through program year 2025, $3,805,367 in general payments and $894,700 in research payments were reported against LCS (Ortho-Knee).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $672,720 | 8 |
| 2025 | Research | $188,050 | 9 |
| 2024 | General | $649,131 | 12 |
| 2024 | Research | $241,075 | 20 |
| 2023 | General | $750,245 | 13 |
| 2023 | Research | $167,375 | 16 |
| 2022 | General | $842,412 | 46 |
| 2022 | Research | $127,950 | 14 |
| 2021 | General | $890,859 | 51 |
| 2021 | Research | $170,250 | 12 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
130 general · 71 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.